Henry Gosebruch

Track

Insider profile

Currently holds positions in Abbvie Inc and Aptinyx Inc

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
50 8% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 58%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Executive Vice President, Chief Strategy Officer Abbvie Inc Dec. 1, 2015 -
Independent Director Aptinyx Inc May 6, 2019 -
Henry Gosebruch's trades of Galapagos NV's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-11
BE Galapagos NV (GLPG)
B Purchase
85,193
141.43
€4,161,802 		85,193 141.43 €4,161,802
2026-05-12 2026-05-08
BE Galapagos NV (GLPG)
B Purchase
30,425
423.46
€500,191 		30,425 423.46 €500,191
2025-03-12 2025-03-12
PrS Proposed sale
95,324
353.94
US$3,191,295 		95,324 353.94 US$3,191,295
2025-02-18 2025-02-18
PrS Proposed sale
6,857
1.67
US$11,462 		6,857 1.67 US$11,462
2023-09-19 2023-09-19
B Purchase
15,000 +inf%
12.62
US$189,370 		15,000 +inf% 12.62 US$189,370
2023-05-11 2023-05-09
US ACELYRIN Inc (SLRN)
B Purchase
50,000 +inf%
18.00
US$900,000 		50,000 +inf% 18.00 US$900,000
2022-05-18 2022-05-16
US Abbvie Inc (ABBV)
S Sale
83,960 -83.5%
155.00
US$13,013,800 		83,960 -83.5% 155.00 US$13,013,800
2022-03-02 2022-03-01
US Abbvie Inc (ABBV)
S Sale
100 -0.6%
149.38
US$14,938 		100 -0.6% 149.38 US$14,938
2022-03-02 2022-03-01
US Abbvie Inc (ABBV)
S Sale
4,000 -19.3%
148.71
US$594,824 		4,000 -19.3% 148.71 US$594,824
2022-03-02 2022-03-01
US Abbvie Inc (ABBV)
S Sale
5,167 -20.0%
147.60
US$762,657 		5,167 -20.0% 147.60 US$762,657
2022-03-02 2022-03-01
US Abbvie Inc (ABBV)
S Sale
15,733 -37.8%
146.81
US$2,309,770 		15,733 -37.8% 146.81 US$2,309,770
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
1,101 -2.6%
149.14
US$164,208 		1,101 -2.6% 149.14 US$164,208
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
8,303 -16.3%
148.62
US$1,234,012 		8,303 -16.3% 148.62 US$1,234,012
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
5,596 -9.9%
147.54
US$825,616 		5,596 -9.9% 147.54 US$825,616
2020-11-24 2020-11-20
US Abbvie Inc (ABBV)
S Sale
33,100 -62.3%
99.49
US$3,293,119 		33,100 -62.3% 99.49 US$3,293,119
2020-11-24 2020-11-20
US Abbvie Inc (ABBV)
S Sale
6,900 -11.5%
98.83
US$681,927 		6,900 -11.5% 98.83 US$681,927
2020-01-14 2020-01-10
US Aptinyx Inc (APTX)
B Purchase
25,000 +25.0%
3.00
US$75,000 		25,000 +25.0% 3.00 US$75,000
2019-07-31 2019-07-29
US Abbvie Inc (ABBV)
B Purchase
30,000 +65.6%
67.28
US$2,018,385 		30,000 +65.6% 67.28 US$2,018,385
2019-05-09 2019-05-08
US Aptinyx Inc (APTX)
B Purchase
96,580 +2824.0%
3.86
US$372,799 		96,580 +2824.0% 3.86 US$372,799
2019-05-09 2019-05-07
US Aptinyx Inc (APTX)
B Purchase
3,420 +inf%
3.75
US$12,825 		3,420 +inf% 3.75 US$12,825
2018-11-30 2018-11-29
US Abbvie Inc (ABBV)
S Sale
42,450 -58.3%
90.10
US$3,824,940 		42,450 -58.3% 90.10 US$3,824,940
2017-10-31 2017-10-30
US Abbvie Inc (ABBV)
S Sale
100 -0.2%
92.02
US$9,202 		100 -0.2% 92.02 US$9,202
2017-10-31 2017-10-30
US Abbvie Inc (ABBV)
S Sale
4,482 -6.4%
91.22
US$408,849 		4,482 -6.4% 91.22 US$408,849
2017-10-31 2017-10-30
US Abbvie Inc (ABBV)
S Sale
11,568 -14.2%
90.49
US$1,046,814 		11,568 -14.2% 90.49 US$1,046,814
2017-10-31 2017-10-30
US Abbvie Inc (ABBV)
S Sale
2,150 -2.6%
89.38
US$192,172 		2,150 -2.6% 89.38 US$192,172
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
70.34
US$7,034 		100 -0.1% 70.34 US$7,034
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
70.29
US$7,029 		100 -0.1% 70.29 US$7,029
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
200 -0.2%
70.25
US$14,050 		200 -0.2% 70.25 US$14,050
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
600 -0.7%
70.23
US$42,138 		600 -0.7% 70.23 US$42,138
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
400 -0.5%
70.22
US$28,088 		400 -0.5% 70.22 US$28,088
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
700 -0.8%
70.21
US$49,147 		700 -0.8% 70.21 US$49,147
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
500 -0.6%
70.20
US$35,100 		500 -0.6% 70.20 US$35,100
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
1,200 -1.4%
70.19
US$84,228 		1,200 -1.4% 70.19 US$84,228
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
300 -0.3%
70.19
US$21,056 		300 -0.3% 70.19 US$21,056
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
500 -0.6%
70.18
US$35,090 		500 -0.6% 70.18 US$35,090
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
200 -0.2%
70.18
US$14,035 		200 -0.2% 70.18 US$14,035
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
400 -0.4%
70.17
US$28,068 		400 -0.4% 70.17 US$28,068
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
600 -0.7%
70.16
US$42,096 		600 -0.7% 70.16 US$42,096
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
70.15
US$7,015 		100 -0.1% 70.15 US$7,015
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
100 -0.1%
70.14
US$7,014 		100 -0.1% 70.14 US$7,014
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
800 -0.9%
70.13
US$56,104 		800 -0.9% 70.13 US$56,104
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
700 -0.8%
70.12
US$49,084 		700 -0.8% 70.12 US$49,084
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
200 -0.2%
70.12
US$14,023 		200 -0.2% 70.12 US$14,023
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
1,000 -1.1%
70.11
US$70,110 		1,000 -1.1% 70.11 US$70,110
2017-08-02 2017-07-31
US Abbvie Inc (ABBV)
S Sale
400 -0.4%
70.10
US$28,040 		400 -0.4% 70.10 US$28,040